2024-10-03

Eli Lilly to build $4.5 billion research and manufacturing center

Eli Lilly will spend $4.5 billion to build a center aimed at finding better ways to manufacture its medicines.  The facility, called the Lilly Medicine Foundry, will house development of new manufacturing methods with an eye toward efficiency. It’s a strategy that’s already paying off with Lilly’s obesity and weight loss drugs Mounjaro and Zepbound, and Lilly wants it…

Read More

2024-09-12

Eli Lilly to boost output of weight loss, diabetes, Alzheimer’s drugs

A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March 17, 2024. Scott Olson | Getty Images Eli Lilly on Thursday said it will invest $1.8 billion to boost manufacturing for its newly approved Alzheimer’s drug and highly popular weight loss and diabetes treatments, among other medicines, in Ireland.  The pharmaceutical…

Read More

2024-08-28

Eli Lilly releases new, cheaper form of weight loss drug

Eli Lilly on Tuesday released a new form of its weight loss drug Zepbound for roughly half its usual monthly list price to reach millions of patients without insurance coverage for the popular injection, such as those with Medicare.  The move also aims to expand the supply of Zepbound in the U.S. as demand skyrockets, and to ensure eligible…

Read More

2024-08-09

Eli Lilly (LLY) earnings Q2 2024

Eli Lilly on Thursday reported second-quarter earnings and revenue that blew past expectations and hiked its full-year revenue outlook by $3 billion as sales of its blockbuster diabetes drug Mounjaro and weight loss injection Zepbound spike. Shares of Eli Lilly closed more than 9% higher on Thursday. The drugmaker now expects revenue for the year to come in between…

Read More